Aslı Okan

405 citations
51 papers · 282 indexed · h-index 10
Topics
Bee Products Chemical Analysis (7 papers)Neuroscience and Neuropharmacology Research (5 papers)Endoplasmic Reticulum Stress and Disease (5 papers)

In The Last Decade

Aslı Okan

43 papers receiving 276 citations

Peers

Aslı Okan
Comparison fields: 5 of 77
  • Molecular Biology 76
  • Pharmacology 55
  • Insect Science 44
  • Immunology 33
  • Physiology 30
Replace Guido Koverech with:
Guido Koverech Italy
Mariann Bombicz Hungary
Chang Mann Ko South Korea
J. Pečivová Slovakia
Dániel Priksz Hungary
Flávia Bittencourt Brasil Brazil
G Repossi Argentina
Andrés García-Sánchez Mexico
Rosa Santangelo Italy
K.R. Hegde United States
Aslı Okan relative to Guido Koverech Italy Guido Koverech's profile →
Citations per field
00.5×7.3×
Guido Koverech · 1×
Citations per year

Countries citing papers authored by Aslı Okan

Since Specialization
Citations

This map shows the geographic impact of Aslı Okan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aslı Okan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aslı Okan more than expected).

Fields of papers citing papers by Aslı Okan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aslı Okan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aslı Okan. The network helps show where Aslı Okan may publish in the future.

Co-authorship network of co-authors of Aslı Okan

This figure shows the co-authorship network connecting the top 25 collaborators of Aslı Okan. A scholar is included among the top collaborators of Aslı Okan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aslı Okan. Aslı Okan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 2
5 2
6 3
7 4
8 4
9 0
10 5
11 1
12 9
13 1
14 12
15 3
16 4
17 2
18
Protective Effect of Propolis and Bee Bread in Experimental Gastric Ulcer Model
2
19 21
20 21

About Aslı Okan

Aslı Okan is a scholar working on Complementary and alternative medicine, Neurology and Nutrition and Dietetics, having authored 51 papers that have together received 282 indexed citations. Recurring topics across this work include Bee Products Chemical Analysis (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Endoplasmic Reticulum Stress and Disease (5 papers). The work is most often cited by research in Insect Science (44 citations), Complementary and alternative medicine (27 citations) and Pharmacology (55 citations). Aslı Okan has collaborated with scholars based in Türkiye, United States and Ukraine. Frequent co-authors include Züleyha Doğanyiğit, Sibel Sılıcı, Emin Kaymak, Dilek Pandır, Seher Yılmaz, Necdet Demır, Enes Akyüz, Suat Tekin, Ece Eroğlu and Murat Çakır. Their work appears in journals such as Scientific Reports, Journal of Hepatology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026